0001209191-18-022003.txt : 20180328 0001209191-18-022003.hdr.sgml : 20180328 20180328211148 ACCESSION NUMBER: 0001209191-18-022003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180326 FILED AS OF DATE: 20180328 DATE AS OF CHANGE: 20180328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGE LOUIS G CENTRAL INDEX KEY: 0001238401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37833 FILM NUMBER: 18720348 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94034 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-26 0 0001628738 Audentes Therapeutics, Inc. BOLD 0001238401 LANGE LOUIS G C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO CA 94108 1 0 0 0 Common Stock 2018-03-26 4 S 0 11568 29.00 D 414231 D Common Stock 2018-03-26 4 S 0 6700 29.57 D 407531 D Common Stock 2018-03-26 4 S 0 1732 29.95 D 405799 D Common Stock 2018-03-26 4 S 0 500 28.284 D 10055 I By Adrienne M. MacMillan Revocable Trust Common Stock 2018-03-26 4 S 0 500 29.464 D 9555 I By Adrienne M. MacMillan Revocable Trust Common Stock 2018-03-26 4 S 0 600 28.38 D 21078 I By Amygdala Lange Trust Common Stock 2018-03-26 4 S 0 400 29.5725 D 20678 I By Amygdala Lange Trust Common Stock 2018-03-26 4 S 0 517 28.3206 D 4041 I By Lange Minor's Trust Common Stock 2018-03-26 4 S 0 483 29.5695 D 3558 I By Lange Minor's Trust Common Stock 2018-03-26 4 S 0 18400 28.3514 D 68943 I By Asset Management Ventures Fund, L.P. Common Stock 2018-03-26 4 S 0 6600 29.2655 D 62343 I By Asset Management Ventures Fund, L.P. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Represents the weighted average sale price. The lowest price at which shares were sold was $27.90 and the highest price at which shares were sold was $28.89. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (8), (9), (11), (12), (14), (15) and (17) to this Form 4. Of the shares sold in this transaction, 3,432 shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Represents the weighted average sale price. The lowest price at which shares were sold was $28.92 and the highest price at which shares were sold was $29.92. Represents the weighted average sale price. The lowest price at which shares were sold was $29.93 and the highest price at which shares were sold was $29.99. Represents the weighted average sale price. The lowest price at which shares were sold was $27.95 and the highest price at which shares were sold was $28.72. The reporting person's domestic partner is the trustee of the Adrienne M. MacMillan Revocable Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. Represents the weighted average sale price. The lowest price at which shares were sold was $29.03 and the highest price at which shares were sold was $29.96. Represents the weighted average sale price. The lowest price at which shares were sold was $27.94 and the highest price at which shares were sold was $28.88. The reporting person's domestic partner is the trustee of the Amygdala Lange Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. Represents the weighted average sale price. The lowest price at which shares were sold was $29.28 and the highest price at which shares were sold was $29.96. Represents the weighted average sale price. The lowest price at which shares were sold was $27.94 and the highest price at which shares were sold was $28.75. The reporting person's domestic partner is the trustee of the Lange Minor's Trust. The reporting person disclaims beneficial ownership of such securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. Represents the weighted average sale price. The lowest price at which shares were sold was $29.03 and the highest price at which shares were sold was $29.97. Represents the average weighted sale price. The lowest price at which shares were sold was $27.91 and the highest price at which shares were sold was $28.89. The reporting person is a general partner of Asset Management Ventures Fund, L.P. ("AMVF L.L.P."), and has shared voting and dispositive power over the shares held by AMVF L.L.P. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. Represents the average weighted sale price. The lowest price at which shares were sold was $28.92 and the highest price at which shares were sold was $29.86. /s/ Thomas Soloway as attorney-in-fact for Louis Lange, M.D., Ph.D. 2018-03-28